ENBIOSIS is a biotechnology company developing next-generation health products through AI-driven microbiome science.
Our technology enables the design of targeted, food-derived formulations that support the body’s own biological pathways across multiple disease and wellness areas.
A Scalable Product Vision
Our platform is designed to address a wide range of microbiome-linked conditions and wellness needs, from chronic diseases to daily health optimization.
Eye Health
Clinical Trial: Completed.
Product: Available.
Hormonal Conditions
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Digestive Disorders
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Weight Management
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Neurological Conditions
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Sexual Health
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Urological Conditions
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Mental Health
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Longevity
Clinical Trial: Planned for 2026 Q2.
Product: Coming Soon.
Our First Product: Dry Eye
Dry Eye was selected as the initial model indication due to its strong microbiome connection and clear clinical endpoints.
The product is designed to support tear production and ocular surface health by guiding microbiome-driven molecular pathways, ddressing the condition from within.
Product Formats
To support different usage preferences and lifestyles, the Dry Eye solution is offered in both powder and bar formats.
The powder form is designed for daily, precise supplementation, while the bar format provides a convenient, on-the-go option. Both formats are built on the same core technology and share the same underlying mechanism of action, ensuring consistent efficacy across use cases.
What’s Next?
ENBIOSIS is building a growing pipeline of microbiome-driven products across multiple disease and wellness areas.
Our technology, formulations, and clinical programs are progressing in parallel with creating long-term opportunities for strategic partners and investors.
Want to partner with us or get early access to our products?
Learn more about our partnership models and how you can benefit from the ENBIOSIS technology.
Get instant access to our peer-reviewed studies, published in world-class journals.
🟥 The American Journal of Gastroenterology – 85% IBS symptom improvement
🟨 Gut Microbes – Microbiome diversity & symptom relief
🟩 Journal of Clinical Medicine – AI diet outperforms laxatives
🟦 Food Bioscience – Probiotic safety alerts
*We’ll send the download link to your inbox. No spam – just science.
Our Spring Sale Has Started
You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/
Login
Please select the partner in your region to get your microbome analysis.
[region_country_table]
Your country is not listed? If interested to become a partner to spread this new health technology in your region please click here.
For other issues feel free to contact our Support.
